It was reported that on (b)(6) 2021, a 16 mm amplatzer septal occluder was chosen for implant, along with an 8f amplatzer¿ trevisio¿ intravascular delivery system.During procedure, the device deployed as a cobra deformation on the first and second deployment attempts.The device was then removed from the patient prior to release from the delivery cable.The device was exchanged for a new 16 mm amplatzer septal occluder, and the same delivery system was reused.The replacement device was successfully implanted to resolve this event.There was no interaction with cardiac structures during deployment.There was no angulation or kink noticed in the delivery system.The patient remained hemodynamically stable throughout the procedure.There was no clinically significant delay in procedure and no adverse patient effects.No additional information was provided.
|
The reported event of cobra deformation could not be confirmed.One photo was received from the field, which appeared to show an occluder being deployed with a cobra deformation.However, the investigation confirmed the device met visual and functional specifications when analyzed at abbott.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met all specifications.The cause of the reported incident could not be conclusively determined.
|